Hepatitis Monthly

Published by: Kowsar

Combination Therapy of Interferon-alpha (PDferon B®) and Ribavirin for Chronic Hepatitis C

Seyed Moayed Alavian 1 , * , Ali Kabir 2 , Behzad Hajarizadeh 2 , Mohsen Nayebpour Pharm 3 , bashir hajibeigi 2 , Taher Doroudi 2 and F. E. Baralle 4
Authors Information
1 Baqiyatallah Hospital Tehran Hepatitis Center, Tehran, IR-Iran
2 Methodology and statistics consultant Tehran Hepatitis Center, Tehran, IR-Iran
3 Assistant professor of pharmacology, Faculty of pharmacy, Tehran University of Medical Sciences, Tehran, IR-Iran
4 Professor and Director of International Center for Genetic Engineering and Biotechnology, Trieste, Italy
Article information
  • Hepatitis Monthly: June 30, 2004, 4 (6); e92940
  • Published Online: May 31, 2004
  • Article Type: Research Article
  • Received: May 05, 2019
  • Accepted: May 31, 2004

To Cite: Alavian S M, Kabir A, Hajarizadeh B, Nayebpour Pharm M, hajibeigi B, et al. Combination Therapy of Interferon-alpha (PDferon B®) and Ribavirin for Chronic Hepatitis C, Hepat Mon. 2004 ; 4(6):e92940.

Abstract
© 2004, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Fulltext
References
  • 1. The References are available in the PDF file.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments